1
|
Bruno A, Milillo C, Anaclerio F, Buccolini C, Dell’Elice A, Angilletta I, Gatta M, Ballerini P, Antonucci I. Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases. Int J Mol Sci 2024; 25:976. [PMID: 38256050 PMCID: PMC10815412 DOI: 10.3390/ijms25020976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2023] [Revised: 01/05/2024] [Accepted: 01/09/2024] [Indexed: 01/24/2024] Open
Abstract
Over the past 20 years, stem cell therapy has been considered a promising option for treating numerous disorders, in particular, neurodegenerative disorders. Stem cells exert neuroprotective and neurodegenerative benefits through different mechanisms, such as the secretion of neurotrophic factors, cell replacement, the activation of endogenous stem cells, and decreased neuroinflammation. Several sources of stem cells have been proposed for transplantation and the restoration of damaged tissue. Over recent decades, intensive research has focused on gestational stem cells considered a novel resource for cell transplantation therapy. The present review provides an update on the recent preclinical/clinical applications of gestational stem cells for the treatment of protein-misfolding diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). However, further studies should be encouraged to translate this promising therapeutic approach into the clinical setting.
Collapse
Affiliation(s)
- Annalisa Bruno
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Cristina Milillo
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Federico Anaclerio
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Carlotta Buccolini
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Anastasia Dell’Elice
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Ilaria Angilletta
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Marco Gatta
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Patrizia Ballerini
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Ivana Antonucci
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (A.B.); (C.M.); (C.B.); (A.D.); (I.A.)
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| |
Collapse
|
2
|
Di Rado S, Giansante R, Cicirelli M, Pilenzi L, Dell’Elice A, Anaclerio F, Rimoldi M, Grassadonia A, Grossi S, Canale N, Ballerini P, Stuppia L, Antonucci I. Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers (Basel) 2023; 15:5730. [PMID: 38136276 PMCID: PMC10741895 DOI: 10.3390/cancers15245730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 11/20/2023] [Accepted: 12/04/2023] [Indexed: 12/24/2023] Open
Abstract
BACKGROUND Several hereditary-familial syndromes associated with various types of tumors have been identified to date, evidencing that hereditary cancers caused by germline mutations account for 5-10% of all tumors. Advances in genetic technology and the implementation of Next-Generation Sequencing (NGS) have accelerated the discovery of several susceptibility cancer genes, allowing for the detection of cancer-predisposing mutations in a larger number of cases. The aim of this study is to highlight how the application of an NGS-multigene panel to a group of oncological patients subsequently leads to improvement in the identification of carriers of healthy pathogenic variants/likely pathogenic variants (PVs/LPVs) and prevention of the disease in these cases. METHODS Starting from a total of 110 cancer patients carrying PVs/LPVs in genes involved in cancer susceptibility detected via a customized NGS panel of 27 cancer-associated genes, we enrolled 250 healthy collateral family members from January 2020 to July 2022. The specific PVs/LPVs identified in each proband were tested in healthy collateral family members via Sanger sequencing. RESULTS A total of 131 out of the 250 cases (52%) were not carriers of the mutation detected in the affected relative, while 119 were carriers. Of these, 81/250 patients carried PVs/LPVs on BRCA1/2 (33%), 35/250 harbored PVs/LPVs on other genes beyond BRCA1 and BRCA2 (14%), and 3/250 (1%) were PVs/LPVs carriers both on BRCA1/2 and on another susceptibility gene. CONCLUSION Our results show that the analysis of BRCA1/2 genes would have only resulted in a missed diagnosis in a number of cases and in the lack of prevention of the disease in a considerable percentage of healthy carriers with a genetic mutation (14%).
Collapse
Affiliation(s)
- Sara Di Rado
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Roberta Giansante
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
- Department of Medical Genetics, “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Michela Cicirelli
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
- Department of Medical Genetics, “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Lucrezia Pilenzi
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Anastasia Dell’Elice
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Federico Anaclerio
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Martina Rimoldi
- SD Genetica Medica, IRCCS Fondazione Ca’Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy;
| | - Antonino Grassadonia
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
- Department of Innovative Technologies in Medicine and Dentistry, “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
| | - Simona Grossi
- U.O.C. Chirurgia Generale ad Indirizzo Senologico, Eusoma Breast Center ASL2 Abruzzo, 66026 Ortona, Italy; (S.G.); (N.C.)
| | - Nicole Canale
- U.O.C. Chirurgia Generale ad Indirizzo Senologico, Eusoma Breast Center ASL2 Abruzzo, 66026 Ortona, Italy; (S.G.); (N.C.)
| | - Patrizia Ballerini
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Liborio Stuppia
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| | - Ivana Antonucci
- Center for Advanced Studies and Technology (CAST), “G. D’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; (S.D.R.); (R.G.); (M.C.); (L.P.); (F.A.); (A.G.); (P.B.); (L.S.); (I.A.)
| |
Collapse
|
3
|
Anaclerio F, Pilenzi L, Dell’Elice A, Ferrante R, Grossi S, Ferlito LM, Marinelli C, Gildetti S, Calabrese G, Stuppia L, Antonucci I. Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis. Front Genet 2023; 14:1060504. [PMID: 37065479 PMCID: PMC10104445 DOI: 10.3389/fgene.2023.1060504] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Accepted: 01/04/2023] [Indexed: 02/04/2023] Open
Abstract
Introduction: A considerable number of families with pedigrees suggestive of a Mendelian form of Breast Cancer (BC), Ovarian Cancer (OC), or Pancreatic Cancer (PC) do not show detectable BRCA1/2 mutations after genetic testing. The use of multi-gene hereditary cancer panels increases the possibility to identify individuals with cancer predisposing gene variants. Our study was aimed to evaluate the increase in the detection rate of pathogenic mutations in BC, OC, and PC patients when using a multi-gene panel.Methods: 546 patients affected by BC (423), PC (64), or OC (59) entered the study from January 2020 to December 2021. For BC patients, inclusion criteria were i) positive cancer family background, ii) early onset, and iii) triple negative BC. PC patients were enrolled when affected by metastatic cancer, while OC patients were all submitted to genetic testing without selection. The patients were tested using a Next-Generation Sequencing (NGS) panel containing 25 genes in addition to BRCA1/2.Results: Forty-four out of 546 patients (8%) carried germline pathogenic/likely pathogenic variants (PV/LPV) on BRCA1/2 genes, and 46 (8%) presented PV or LPV in other susceptibility genes.Discussion: Our findings demonstrate the utility of expanded panel testing in patients with suspected hereditary cancer syndromes, since this approach increased the mutation detection rate of 15% in PC, 8% in BC and 5% in OC cases. In absence of multi-gene panel analysis, a considerable percentage of mutations would have been lost.
Collapse
Affiliation(s)
- Federico Anaclerio
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
| | - Lucrezia Pilenzi
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
| | - Anastasia Dell’Elice
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
| | - Rossella Ferrante
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
- *Correspondence: Rossella Ferrante,
| | - Simona Grossi
- Eusoma Breast Centre, “G. Bernabeo” Hospital, Ortona, Italy
| | | | | | | | - Giuseppe Calabrese
- UOSD Genetica Oncoematologica, Dipartimento di Oncologico-Ematologico, Pescara, Italy
| | - Liborio Stuppia
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
| | - Ivana Antonucci
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
4
|
Antonucci I, Angilletta I, Anaclerio F. The role of CFTR p.G970D missense mutation in male infertility. Asian J Androl 2022; 25:143. [PMID: 35899923 PMCID: PMC9933964 DOI: 10.4103/aja202260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Affiliation(s)
- Ivana Antonucci
- Center for Advanced Studies and Technology (CAST), G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy,Department of Psychological Health and Territory Science, School of Medicine and Health Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy,
Correspondence: Dr. I Antonucci ()
| | - Ilaria Angilletta
- Center for Advanced Studies and Technology (CAST), G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy,Department of Psychological Health and Territory Science, School of Medicine and Health Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy
| | - Federico Anaclerio
- Center for Advanced Studies and Technology (CAST), G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy,Department of Psychological Health and Territory Science, School of Medicine and Health Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti 66100, Italy
| |
Collapse
|
5
|
Anaclerio F, Ferrante R, Mandatori D, Antonucci I, Capanna M, Damiani V, Tomo PD, Ferrante R, Ranaudo M, De Laurenzi V, Stuppia L, De Fabritiis S. Different Strategies for the Identification of SARS-CoV-2 Variants in the Laboratory Practice. Genes (Basel) 2021; 12:genes12091428. [PMID: 34573410 PMCID: PMC8467753 DOI: 10.3390/genes12091428] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 09/14/2021] [Indexed: 01/24/2023] Open
Abstract
A considerable effort has been devoted in all countries to react to the COVID-19 pandemic by tracing infected individuals, containing the spread of the disease, identifying therapies, and producing and distributing vaccines. Currently, a significant concern is the appearance of variants of the virus that may frustrate these efforts by showing increased transmissibility, increased disease severity, reduced response to therapy or vaccines, and ability to escape diagnosis. All countries have therefore devoted a massive attempt to the identification and tracking of these variants, which requires a vast technological effort to sequence a large number of viral genomes. In this paper, we report our experience as one of the Italian laboratories involved in SARS-CoV-2 variant tracing. We summarize the different approaches used, and outline a potential model combining several techniques to increase tracing ability while at the same time minimizing costs.
Collapse
Affiliation(s)
- Federico Anaclerio
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
| | - Rossella Ferrante
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
| | - Domitilla Mandatori
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Medical Oral and Biotechnological Sciences, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
- Correspondence:
| | - Ivana Antonucci
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Psicological Health and Territory Science, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Matteo Capanna
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
| | - Verena Damiani
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Innovative Technologies in Medicine and Dentistry, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Pamela Di Tomo
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Medical Oral and Biotechnological Sciences, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Roberto Ferrante
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
| | - Marianna Ranaudo
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
| | - Vincenzo De Laurenzi
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Innovative Technologies in Medicine and Dentistry, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Liborio Stuppia
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Psicological Health and Territory Science, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Simone De Fabritiis
- Center for Advanced Studies and Technology (CAST), G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; (F.A.); (R.F.); (I.A.); (M.C.); (V.D.); (P.D.T.); (R.F.); (M.R.); (V.D.L.); (L.S.); (S.D.F.)
- Department of Medicine and Aging Sciences, School of Medicine and Health Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| |
Collapse
|